Nanoparticles with Surface Antibody Against CD98 and Carrying CD98 Small Interfering RNA Reduce Colitis in Mice

BACKGROUND & AIMS: Nanoparticles have been explored as carriers of small interfering RNAs (siRNAs), and might developed to treat inflammatory bowel disease (IBD). Overexpression of CD98 on the surface of colonic epithelial cells and macrophages promotes development and progression of IBD. We dev...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiao, Bo, Laroui, Hamed, Viennois, Emilie, Ayyadurai, Saravanan, Charania, Moiz A., Zhang, Yuchen, Zhang, Zhan, Baker, Mark T., Zhang, Benyue, Gewirtz, Andrew T., Merlin, Didier
Format: Artigo
Language:Inglês
Published: 2014
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3992175/
https://ncbi.nlm.nih.gov/pubmed/24503126
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2014.01.056
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items